Emulent Let’s Talk
Skip links

How to build links in regulated industries where content gets scrutinized

Author: Bill Ross, founder of Emulent Published Article

Key takeaways

  • Healthcare, finance, legal and pharmaceutical content faces rules that limit claims, testimonials and patient or client stories, so link building has to work inside those rules.
  • Rules differ by field. The SEC’s Marketing Rule, for example, has allowed registered investment advisers to use testimonials since November 4, 2022, but only with required disclosures and oversight.
  • Regulatory explainers, association contributions, conference talks and expert commentary earn links that competitors cutting corners cannot.
  • Build compliance review into planning from the start rather than treating it as a final gate.
  • Google weighs trust heavily for “Your Money or Your Life” topics, so expert authorship and cited sources support both compliance and search performance.
Quick answers
Question Short answer
Which link building strategies work in regulated industries? Strategies built on demonstrated expertise within the rules.
How do you integrate compliance into the link building workflow? Bring reviewers in early and give the team approved building blocks.
How does E-E-A-T benefit regulated industry content? E-E-A-T rewards the same rigor compliance demands.

Link building in regulated industries runs on constraints most SEO advice ignores. Claims need evidence, testimonials may be restricted and every piece goes through review. Those limits also create an advantage: firms that publish accurate, expert content earn links from associations, publications and institutions that will not touch questionable material. This Emulent guide covers how to do it.

Every asset and every pitch must survive legal or clinical review.

  • Claims need support. Health outcomes need clinical evidence, financial content cannot promise returns, and legal marketing must follow state bar advertising rules.
  • Testimonials vary by field. Healthcare providers need written patient authorization under HIPAA before sharing protected health information in a story. The SEC Marketing Rule permits adviser testimonials and endorsements subject to disclosures, while broker-dealers follow FINRA Rule 2210.
  • Prescription drug promotion must meet FDA requirements such as fair balance between benefits and risks.
  • Review cycles add days or weeks, which affects timely PR and source requests.
  • Competitors’ aggressive tactics may not be compliant, so copying them can create legal exposure.

Strategies built on demonstrated expertise within the rules.

  • Regulatory guides that explain complex rules plainly, which professionals and businesses cite.
  • Conference talks, which often earn speaker-page links and coverage.
  • Contributions to professional associations, such as committee reports or member education.
  • Expert commentary for trade and consumer media, prepared with pre-approved talking points.
  • Continuing education content and webinars, which associations and licensing bodies may list.
  • Research partnerships with universities, producing citations from academic sites.

In healthcare marketing and pharmaceutical marketing, clinician-reviewed resources often earn links from patient advocacy groups and medical societies that ignore promotional content.

Bring reviewers in early and give the team approved building blocks.

  • Consult compliance or legal when choosing topics and angles, not after drafting.
  • Create templates for recurring pieces, such as regulatory updates and expert quotes, with pre-approved language.
  • Maintain a library of approved claims, statistics and disclaimers.
  • Plan timelines that include review time, and prepare commentary on predictable topics in advance.
  • Avoid tracking pixels on pages with sensitive health information unless your setup and agreements comply with HIPAA guidance.

How does E-E-A-T benefit regulated industry content?

E-E-A-T rewards the same rigor compliance demands. Google’s helpful content guidance explains that its systems give even more weight to signals of experience, expertise, authoritativeness and trust for topics that could significantly affect health, finances or safety. E-E-A-T is a framework raters use, not a single ranking factor, but the practices behind it count.

  • Expert authors and reviewers with visible credentials, such as licensed physicians, attorneys or CFPs.
  • Citations to primary sources such as regulators, peer-reviewed research and official guidance.
  • Clear organizational details: licensing, accreditation, contact information and editorial policies.

Content built this way is easier for associations and journalists to cite, which is how regulated firms earn the strongest links.

How can the Emulent team help?

Emulent builds link strategies for healthcare, pharmaceutical, legal, financial and other regulated clients, with compliance review built into every asset and pitch. A caveat: this article is general information, not legal advice; your counsel and compliance team should approve specific claims and disclosures. Contact the Emulent team to plan compliant link building.

Want a second set of eyes on your marketing? We’ll show you the math before asking for a contract. No long-term lock-ins.
Let’s Talk